What are INDmoney investors doing with Glaxosmithkline Pharmaceuticals shares?
Based on platform-user behaviour - not analyst opinion or company fundamentals.
Search interest on INDmoney
+38%
Searches for Glaxosmithkline Pharmaceuticals on INDmoney have increased by 38% over the last 30 days.
Among the most traded stocks
451st
Glaxosmithkline Pharmaceuticals was the 451st most traded stock on INDmoney over the last 7 days.
Average holding period of indmoney investors
34 days
INDmoney investors hold Glaxosmithkline Pharmaceuticals shares for an average of 34 days.
Key Events for Glaxosmithkline Pharmaceuticals
Glaxosmithkline Pharmaceuticals Stock Performance
as on November 19, 2026 at 9:31 pm IST
Day's Low
Day's High
₹2,595.90₹2,719.90
4.33%
Downside
0.24%
Upside

52 Week's Low
52 Week's High
₹2,088.10₹3,120.70
23.04%
Downside
15.01%
Upside

Glaxosmithkline Pharmaceuticals share price movements today
- Previous Close
- ₹2,638.20
- Open
- ₹2,635.30
- Volume
- 1.23L
- Upper Circuit
- ₹3,165.80
- Lower Circuit
- ₹2,110.60
- Day's Low - High
- ₹2,595.90 - ₹2,719.90
- 52 Week Low - High
- ₹2,088.10 - ₹3,120.70
Glaxosmithkline Pharmaceuticals Historical Returns
- 1 Month Return
- + 5.72 %
- 3 Month Return
- -13 %
- 1 Year Return
- + 4.73 %
- 3 Year Return
- + 60.09 %
- 5 Year Return
- + 65.16 %
Glaxosmithkline Pharmaceuticals Fundamentals
as on November 19, 2026 at 4:01 pm IST
Market Cap
₹44,692.70 Cr
Return on Equity (ROE)
48.29
PE Ratio (TTM)
39.51
Return on capital employed (ROCE)
58.17
Industry PE ratio
53.92
Beta (LTM)
0.46
P/B Ratio
17.26
Dividend Yield
2.5
PEG Ratio
3.76
Quarterly Earnings Growth YOY
30.44
EPS (TTM)
61.15
Book Value
133.85
Glaxosmithkline Pharmaceuticals Stock Valuation
as on November 19, 2026 at 4:01 pm IST
Glaxosmithkline Pharmaceuticals in the last 5 years
Lowest (-81.64x)
December 28, 2020
Today (39.51x)
November 18, 2026
Industry (53.92x)
November 18, 2026
Highest (333.07x)
September 15, 2020
Today’s Price to Earnings Ratio: 39.51x
Glaxosmithkline Pharmaceuticals Technical Analysis
Track how Glaxosmithkline Pharmaceuticals technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | -0.14 | |
CCI (20) | -653.37 | Bullish |
RSI (14) | 41.28 | Neutral |
Momentum (10) | -4.4 | |
ADI (14) | 19.86 | Neutral |
Ultimate Oscillator (7,14,28) | 85.11 | Bullish |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 2713.63 | |
EMA (20) | 2713.17 | |
VWMA (20) | 2713.39 | |
SMA (50) | 2712.57 | |
EMA (50) | 2711.45 | |
SMA (200) | 2692.94 | Bullish |
EMA (200) | 2694.32 | Bullish |
KAMA (200) | 2710.55 | |
DEMA (200) | 2713.89 |
Glaxosmithkline Pharmaceuticals Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Glaxosmithkline Pharmaceuticals with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 44,692.70 | 13.03% | 0.56 | 1,035 | 3,821 | |
| BUY | 7,442.84 | -11.99% | 0.00 | 326 | 1,837 | |
| BUY | 1,03,355.13 | 37.24% | 0.60 | 3,502 | 33,653 | |
| BUY | 1,19,899.96 | 32.68% | 0.69 | 5,026 | 51,180 | |
| BUY | 54,123.75 | 6.11% | 0.00 | 1,414 | 6,445 |
Market expectation of Glaxosmithkline Pharmaceuticals Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
75.00%
Buy
25.00%
Hold
0.00%
Sell
Glaxosmithkline Pharmaceuticals Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Glaxosmithkline Pharmaceuticals Ltd Annual Profit & Loss
Figures in Rupees Crores
Glaxosmithkline Pharmaceuticals Ltd Cash Flow
Figures in Rupees Crores
Glaxosmithkline Pharmaceuticals Corporate Actions
View detailed summary of the earnings and dividend history of Glaxosmithkline Pharmaceuticals.
Glaxosmithkline Pharmaceuticals Ltd Earnings Results
Glaxosmithkline Pharmaceuticals Ltd’s net profit jumped 30.44% since last year same period to ₹335.88Cr in the Q2 2026-2027. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 41.61% jump in its net profits since last 3-months.
Read MoreGlaxosmithkline Pharmaceuticals Ltd Dividends May,2026
In the quarter ending March 2026, Glaxosmithkline Pharmaceuticals Ltd has declared dividend of ₹57.00 per share on 13 May 2026 - translating a dividend yield of 2.12%.
Read More about Dividends
Indices Featuring Glaxosmithkline Pharmaceuticals Stock
Check stock indices that include Glaxosmithkline Pharmaceuticals.
Insights on Glaxosmithkline Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up

Mutual Funds have increased holdings from 4.87% to 6.07% in Sep 2026 quarter
POSITIVE IMPACTProfit Spike

Netprofit is up for the last 2 quarters, 237.18 Cr → 335.88 Cr (in ₹), with an average increase of 29.4% per quarter
POSITIVE IMPACTPrice Rise

In the last 1 month, GLAXO stock has moved up by 5.7%
POSITIVE IMPACTRevenue Rich

Revenue is up for the last 2 quarters, 982.2 Cr → 1.25K Cr (in ₹), with an average increase of 21.8% per quarter
NO EFFECTAgainst Peers

In the last 3 years, Laurus Labs Ltd has given 531.0% return, outperforming this stock by 470.9%
NO EFFECTAgainst Peers

In the last 1 year, Laurus Labs Ltd has given 135.2% return, outperforming this stock by 130.5%
NO EFFECTPromoter Holding Unchanged

Promoters holdings remained unchanged at 75.00% of holdings in Sep 2026 quarter
NEGATIVE IMPACTFII Holding Down

Foreign Institutions have decreased holdings from 4.79% to 4.75% in Sep 2026 quarter
NEGATIVE IMPACTRetail Holding Down

Retail Investor have decreased holdings from 12.41% to 11.77% in Sep 2026 quarter
About Glaxosmithkline Pharmaceuticals Ltd
Revenue: ₹1,183.57Cr as on September 2026 (Q2 FY27)
Net Profit: ₹335.88Cr as on September 2026 (Q2 FY27)
Listing date: 03 Nov, 1994
Chairperson Name: Renu S Karnad
| Organisation | Glaxosmithkline Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| CEO | Renu S Karnad |
| E-voting on shares | Click here to vote |
FAQs
What is Glaxosmithkline Pharmaceuticals share price today?
Glaxosmithkline Pharmaceuticals share price today stands at ₹2713.4 as on at the close of the market. Glaxosmithkline Pharmaceuticals share today touched a day high of ₹2719.9 and a low of ₹2595.9.
What is the 52 week high and 52 week low range for Glaxosmithkline Pharmaceuticals share?
Glaxosmithkline Pharmaceuticals touched a 52 week high of ₹3120.7 and a 52 week low of ₹2088.1. Glaxosmithkline Pharmaceuticals share price today i.e. is closed at ₹2713.4, which is -13.05% down from its 52 week high and 29.95% up from its 52 week low.
What is Glaxosmithkline Pharmaceuticals's market capitalisation today?
Glaxosmithkline Pharmaceuticals market capitalisation is ₹44,692.70 Cr as on .
How to buy Glaxosmithkline Pharmaceuticals shares?
To buy Glaxosmithkline Pharmaceuticals shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for GLAXO or Glaxosmithkline Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Glaxosmithkline Pharmaceuticals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Glaxosmithkline Pharmaceuticals trading volume today?
Glaxosmithkline Pharmaceuticals trading volume is 1.23L as on . This means that 1.23L shares of Glaxosmithkline Pharmaceuticals were bought and sold on the stock market during today's trading session.